Phase 1 Randomized, Controlled, Double-blind Study to Compare the Safety and Effectiveness of Hepatitis B Vaccines in Individuals With Renal Impairment, Diabetes Mellitus or Age Greater Than 40 Years
Phase of Trial: Phase I
Latest Information Update: 20 Dec 2016
At a glance
- Drugs Hepatitis B vaccine (Primary) ; ADVAX; Alum
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Vaxine
- 15 Dec 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 15 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 08 Dec 2015 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017 as reported by ClinicalTrials.gov.